Abstract:Recent basic and clinical evidence indicate that renin-angiotensin system (RAS) is involved in metabolic syndrome and diabetes mellitus (DM) as well as hypertension. Metabolic syndrome and DM have been reported to be crucial risk factor for cognitive impairment including Alzheimer's disease. Increasing number of patients with metabolic syndrome and DM suggests that such cognitive decline will become a major worldwide clinical problem in the future. Here, we investigated the roles of angiotensin II and effect of angiotensin II receptor blockers (ARB) in cognitive function. Various mice models were employed. C57BL/6J mice with normal diet (ND), C57BL/6J mice with high-salt and high-cholesterol diet (HCD) as metabolic syndrome-like state, KK-Ay mice as type 2DM, and Tsukuba-Hypertensive-Mice (THM) as human angiotensin II overproducing model were employed in this study. These mice were subjected to passive avoidance task every week with or without ARB. 1) HCD mice showed a significant reduction of avoidance rate compared with ND mice. This impairment was prevented by treatment with non-hypotensive dose of ARB, olmesartan, partly due to a decrease in superoxide anion production. 2) Learning ability evaluated by an increase in avoidance rate was less in KK-Ay mice and significant cognitive impairment was observed after 14 weeks-old. Administration of non-hypotensive dose of candesartan from 8 weeks-old markedly improved learning ability and its administration from 14 weeks-old prevented further cognitive decline. Candesartan significantly decreased serum glucose and insulin levels and increase glucose-uptake in the brain. 3) THM exhibited a failure to increase the avoidance rate compared with control mice. Treatment with ARB, olmesartan, which decreases blood pressure to the same level as C57BL/6J, improved the avoidance rate. However, treatment with hydralazine for the THM did not show an improvement of avoidance rate although hydralazine decreased blood pressure to the same level of olmesartan treatment. Olmesartan attenuated superoxide anion production in the brain and improved the reduction of cerebral blood flow observed in THM. These results suggest that brain RAS plays an important role in cognitive function. Regulation of RAS using ARB is expected to prevent cognitive decline associated with metabolic syndrome, DM and hypertension.

Mineralocorticoid receptor antagonist‐mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF‐H2S‐Nrf2 signaling

A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.

Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior]

Neurochemical Mechanisms of a Novel Alzheimer′s Disease Therapeutics on Improvement of Cognition and Depressive Behavior

Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101) Treatment Rescues Olfactory Bulbectomy-Induced Memory Impairment by Activating Ca2+/Calmodulin Kinase II and Protein Kinase C in Mouse Hippocampus

Hydrogen Sulfide Attenuates Spatial Memory Impairment and Hippocampal Neuroinflammation in Beta-Amyloid Rat Model of Alzheimer’s Disease

Neuroprotective Effects of Spinosin on Recovery of Learning and Memory in a Mouse Model of Alzheimer’s Disease

Xanthoceraside attenuates amyloid β peptide1-42-induced memory impairments by reducing neuroinflammatory responses in mice

S -Propargyl-cysteine (ZYZ-802), a Sulphur-Containing Amino Acid, Attenuates Beta-Amyloid-induced Cognitive Deficits and Pro-Inflammatory Response: Involvement of ERK1/2 and NF-κB Pathway in Rats

Schizandrin, an Antioxidant Lignan from Schisandra Chinensis, Ameliorates Aβ1–42-Induced Memory Impairment in Mice

Exogenous Aβ1-42 monomers improve synaptic and cognitive function in Alzheimer's disease model mice

Selective orexin 1 receptor antagonist SB-334867 aggravated cognitive dysfunction in 3xTg-AD mice

O4‐01‐04: Beneficial Effects of Angiotensin II Receptor Blockers on Metabolic Disorder‐induced Cognitive Impairment

Dopamine D1 receptor agonist A-68930 ameliorates Aβ1-42-induced cognitive impairment and neuroinflammation in mice

Sodium tanshinone IIA sulfonate improves cognitive impairment via regulating Aβ transportation in AD transgenic mouse model

Activation of the Cb2 Receptor System Reverses Amyloid-Induced Memory Deficiency

P23 Saikosaponin a Ameliorate Learning and Memory Impairment Via Anti-Inflammation Effect in an AD Mouse Model

Brain-derived Neurotrophic Factor Ameliorates Learning Deficits in a Rat Model of Alzheimer's Disease Induced by Aβ1-42.

Methylprednisolone alleviates cognitive functions through the regulation of neuroinflammation in Alzheimer's disease

5-HT1AR alleviates Aβ-induced cognitive decline and neuroinflammation through crosstalk with NF-κB pathway in mice

Paeonol Ameliorates Cognitive Deficits in Streptozotocin Murine Model of Sporadic Alzheimer’s Disease via Attenuation of Oxidative Stress, Inflammation, and Mitochondrial Dysfunction